Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | 56.41 |
| peg ratio | 7.45 |
| price to book ratio | 16.57 |
| price to sales ratio | 10.12 |
| enterprise value multiple | 39.08 |
| price fair value | 16.57 |
profitability ratios | |
|---|---|
| gross profit margin | 48.79% |
| operating profit margin | 30.01% |
| pretax profit margin | 19.16% |
| net profit margin | 17.8% |
| return on assets | 17.44% |
| return on equity | 38.43% |
| return on capital employed | 33.23% |
liquidity ratio | |
|---|---|
| current ratio | 7.09 |
| quick ratio | 3.26 |
| cash ratio | 1.93 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 319.90 |
| operating cycle | 367.70 |
| days of payables outstanding | 29.83 |
| cash conversion cycle | 337.87 |
| receivables turnover | 7.63 |
| payables turnover | 12.24 |
| inventory turnover | 1.14 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.29 |
| debt equity ratio | 0.48 |
| long term debt to capitalization | 0.30 |
| total debt to capitalization | 0.32 |
| interest coverage | 6.65 |
| cash flow to debt ratio | 0.77 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.34 |
| cash per share | 0.37 |
| operating cash flow per share | 0.37 |
| free cash flow operating cash flow ratio | 0.92 |
| cash flow coverage ratios | 0.77 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 12.51 |
Frequently Asked Questions
ADMA Biologics, Inc. (ADMA) published its most recent earnings results on 07-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ADMA Biologics, Inc. (NASDAQ:ADMA)'s trailing twelve months ROE is 38.43%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ADMA Biologics, Inc. (ADMA) currently has a ROA of 17.44%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
ADMA reported a profit margin of 17.8% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 7.09 in the most recent quarter. The quick ratio stood at 3.26, with a Debt/Eq ratio of 0.48.